Results 211 to 219 of about 28,066 (219)

Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans

Circulation, 2017
Alice H Lichtenstein, Henry Ginsberg, Gissette Reyes-Soffer   +2 more
exaly  

Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study

International Journal of Cardiology, 2017
Michalina Kołodziejczak, Jolanta Maria Siller-Matula, Antonino Buffon   +2 more
exaly  

Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes

Atherosclerosis, 2020
Gilles Lambert, Matthieu Wargny, Valentin Blanchard   +2 more
exaly  

PCSK9: A novel inflammation modulator in atherosclerosis?

Journal of Cellular Physiology, 2019
Xi-Long Zheng, Zhihan Tang
exaly  

Cross-talk between LOX-1 and PCSK9 in vascular tissues

Cardiovascular Research, 2015
Zufeng Ding, Xianwei Wang, Yubo Fan
exaly  

Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population

Atherosclerosis, 2010
Hongwen Zhou, Jason S Troutt, Joseph V Haas   +2 more
exaly  

Molecular basis of PCSK9 function

Atherosclerosis, 2009
Gilles Lambert, Kerry-Anne Rye, Francesca Charlton   +2 more
exaly  

A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor

Cell
Helena Jernström, Sohail Tavazoie, Christopher Godina   +2 more
exaly  

PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study

Atherosclerosis, 2016
Hector Manuel Garcia-Garcia, Isabella Kardys, Rohit M Oemrawsingh   +2 more
exaly